2026-01-04 - Analysis Report
Okay, here's a comprehensive analysis of Schrodinger Inc. (SDGR) based on the data provided.

**0. Report Introduction**

This report analyzes the current financial health and market sentiment surrounding Schrodinger Inc. (SDGR) using various financial metrics, news articles, and analyst opinions. It compares SDGR's performance against the S&P 500 (VOO) and provides insights for potential investors.

**1. Return Rate Comparison**

*   **Ticker:** SDGR
*   **Company Overview:** Schrodinger Inc. is a company that develops and sells software for drug discovery and materials science.
*   **SDGR Cumulative Return:** -54.41%
*   **VOO Cumulative Return:** 64.25%
*   **Divergence:** -120.0 (Relative Divergence: 1.4)

**Analysis:**

SDGR has significantly underperformed the S&P 500 (VOO) over the period examined. The cumulative return is drastically negative compared to the positive return of the S&P 500. The divergence is a large negative value, indicating a considerable difference in performance. A relative divergence of 1.4 suggests that this level of underperformance is close to the most extreme negative divergence observed in the historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD   | Alpha     | Beta   | Cap(B) |
|------------|----------|-------|-----------|--------|--------|
| 2021-2023  | -57.0%   | 52.9% | -58.0%    | 1.8    | 2.6    |
| 2022-2024  | 6.0%     | 46.6% | -13.0%    | 1.8    | 1.4    |
| 2023-2025  | -4.0%   | 46.6% | -66.0%    | 1.8    | 1.3    |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate is negative or minimal in all periods, indicating poor investment returns.
*   **MDD:** The Maximum Drawdown is consistently high, showing substantial risk and potential loss.
*   **Alpha:**  The Alpha is significantly negative, indicating that SDGR is underperforming relative to its risk-adjusted expected return, i.e., underperforming compared to market index.
*   **Beta:** Beta is consistently high, suggesting that SDGR's price is volatile and highly correlated with the overall market. A Beta of 1.8 means SDGR is about 80% more volatile than the S&P 500.
*   **Cap(B):** Market Capitalization is decreasing, suggesting shrinking investor confidence or business contraction.

**2. Recent Stock Price Fluctuations**

*   **Close:** 17.98
*   **Last-market:** {'price': 17.98, 'previousClose': 17.88, 'change': 0.56}
*   **5-day SMA:** 17.96
*   **20-day SMA:** 18.03
*   **60-day SMA:** 18.78

**Analysis:**

The stock price is currently below both its 20-day and 60-day Simple Moving Averages (SMA), suggesting a potential short-term downtrend. However, the 5-day SMA is slightly below the current close price, indicating a potential near-term stabilization or slight rebound. The change of 0.56 suggests some positive momentum in the very short term.

**3. Technical Indicators & Expected Return**

*   **MRI:** 0.8 (Medium Investment Recommended)
*   **RSI:** 48.56
*   **PPO:** 0.13
*   **Hybrid Signal:** Buy 90% of cash (50 shares - Safe - MRI:0.80). Monthly invest 1.4% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   **Recent (20 days) relative divergence change:** -0.4 (Short-term decline)
*   **Expected Return (%):** -4509.7%

**Analysis:**

*   **MRI:** A Medium Investment Recommended score suggest medium-risk investment.
*   **RSI:** The RSI (Relative Strength Index) of 48.56 is neutral, not indicating overbought or oversold conditions.
*   **PPO:** The PPO (Percentage Price Oscillator) of 0.13 is slightly positive, suggesting a potential weak uptrend.
*   **Hybrid Signal:** The hybrid signal recommends buying 90% of cash with a monthly investment strategy, suggesting a cautious but optimistic approach.
*   **Recent Relative Divergence Change:** The negative divergence change over the past 20 days signals a short-term downward trend.
*   **Expected Return:** The extremely negative Expected Return suggests a highly unfavorable long-term outlook for the stock, although, it may be due to a miscalculation in expected return calculation, given the recent upgrades to SDGR.

**4. Recent News & Significant Events**

*   **Positive News:** The news headlines are generally positive, including an upgrade from BofA, analyst price target increases, and articles suggesting SDGR as a potential "buy the bottom" stock. The "strategic pivot to software" mentioned in the BofA upgrade is a key positive development.
*   **Mixed News:** The comparison article between RXRX and SDGR provides a balanced perspective but acknowledges SDGR's potential.

**Impact:**

The recent positive news and analyst upgrades could be driving short-term price increases, as evidenced by the "Shares Gap Up After Analyst Upgrade" headline. However, the long-term financial performance needs to be considered.

**4-2. Analyst Opinions**

*   **Consensus:** No clear consensus (no Buy/Sell rating indicated).
*   **Target Price:** Average target price of $27.22, with a high of $33.00 and a low of $18.00.
*   **Recent Rating Changes:** Upgrades have occurred, indicating improving analyst sentiment.

**Analysis:**

While there isn't a strong consensus, the target price range suggests analysts see potential upside from the current price of $17.98. The recent upgrades are a positive sign, signaling a change in analyst sentiment, but upgrades were omitted.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-11-05 | -0.45 | 0.05 B$    |
| 2025-08-06 | -0.59 | 0.05 B$    |
| 2025-05-07 | -0.82 | 0.06 B$    |
| 2024-11-12 | -0.52 | 0.04 B$    |
| 2025-11-05 | -0.52 | 0.04 B$    |

**Analysis:**

*   **EPS:** The Earnings Per Share (EPS) is consistently negative, indicating that the company is not currently profitable.
*   **Revenue:** Revenue has been relatively flat, around $0.04-$0.06 billion per quarter.

**Interpretation:** The negative EPS and stagnant revenue highlight concerns about the company's profitability and growth.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $0.05B  | 51.61%        |
| 2025-06-30   | $0.05B  | 47.77%        |
| 2025-03-31   | $0.06B  | 52.26%        |
| 2024-12-31   | $0.09B  | 72.61%        |
| 2024-09-30   | $0.04B  | 50.24%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE      |
|--------------|---------|----------|
| 2025-09-30   | $0.32B  | -10.21%  |
| 2025-06-30   | $0.34B  | -12.59%  |
| 2025-03-31   | $0.37B  | -16.01%  |
| 2024-12-31   | $0.42B  | -9.54%   |
| 2024-09-30   | $0.45B  | -8.49%   |

**Analysis:**

*   **Revenue:** Revenue is relatively stable.
*   **Profit Margin:** Profit Margins are healthy.
*   **Equity:** Equity is decreasing, indicating potential financial strain or capital depletion.
*   **ROE:** Return on Equity (ROE) is negative, confirming the company's lack of profitability and inefficient use of equity.

**7. Comprehensive Analysis (Summary)**

Schrodinger Inc. (SDGR) is currently in a complex situation.

*   **Negative Performance:** The stock has significantly underperformed the S&P 500, and historical data indicates consistent negative Alpha and high Beta, signaling underperformance and volatility.
*   **Improving Sentiment:** Recent news and analyst upgrades suggest a potential turnaround, possibly driven by the strategic shift towards software. Target prices indicate potential upside.
*   **Financial Concerns:** Earnings remain negative, and equity is decreasing, raising concerns about long-term financial sustainability.
*   **Technical Indicators:** Technical indicators present a mixed picture. RSI is neutral, PPO slightly positive, but the recent divergence change is negative.

**Overall Recommendation:**

Given the mixed signals, a cautious approach is warranted. While recent news and analyst upgrades may offer short-term gains, the underlying financial performance is still concerning. Investors should carefully weigh the potential upside against the considerable risks associated with this stock. Further monitoring of earnings, equity trends, and the impact of the strategic software pivot is recommended.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.